{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:19:18Z","timestamp":1792070358952,"version":"4.4.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8046","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Polygenic genome editing in human embryos and germ cells is predicted to become feasible in the next three decades. Several recent books and academic papers have outlined the ethical concerns raised by germline genome editing and the opportunities that it may present<jats:sup>1\u20133<\/jats:sup>. To date, no attempts have been made to predict the consequences of altering specific variants associated with polygenic diseases. In this Analysis, we show that polygenic genome editing could theoretically yield extreme reductions in disease susceptibility. For example, editing a relatively small number of genomic variants could make a substantial difference to an individual\u2019s risk of developing coronary artery disease, Alzheimer\u2019s disease, major depressive disorder, diabetes and schizophrenia. Similarly, large changes in risk factors, such as low-density lipoprotein cholesterol and blood pressure, could, in theory, be achieved by polygenic editing. Although heritable polygenic editing (HPE) is still speculative, we completed calculations to discuss the underlying ethical issues. Our modelling demonstrates how the putatively positive consequences of gene editing at an individual level may deepen health inequalities. Further, as single or multiple gene variants can increase the risk of some diseases while decreasing that of others, HPE raises ethical challenges related to pleiotropy and genetic diversity. We conclude by arguing for a collectivist perspective on the ethical issues raised by HPE, which accounts for its effects on individuals, their families, communities and society<jats:sup>4<\/jats:sup>.<\/jats:p>","DOI":"10.1038\/s41586-024-08300-4","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:02:43Z","timestamp":1736352163000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Heritable polygenic editing: the next frontier in genomic medicine?"],"prefix":"10.1038","volume":"637","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-8760","authenticated-orcid":false,"given":"Peter M.","family":"Visscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gyngell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Yengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1691-6403","authenticated-orcid":false,"given":"Julian","family":"Savulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"8300_CR1","volume-title":"CRISPR People: The Science and Ethics of Editing Humans","author":",HT Greely","year":"2022","unstructured":"Greely, H. T. CRISPR People: The Science and Ethics of Editing Humans (MIT, 2022)."},{"key":"8300_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/japp.12249","volume":"34","author":"C Gyngell","year":"2017","unstructured":"Gyngell, C., Douglas, T. & Savulescu, J. The ethics of germline gene editing. J. Appl. Philos. 34, 498\u2013513 (2017).","journal-title":"J. Appl. Philos."},{"key":"8300_CR3","doi-asserted-by":"publisher","DOI":"10.4159\/9780674241954","volume-title":"Altered Inheritance: CRISPR and the Ethics of Human Genome Editing","author":",F Baylis","year":"2019","unstructured":"Baylis, F. Altered Inheritance: CRISPR and the Ethics of Human Genome Editing (Harvard Univ. Press, 2019)."},{"key":"8300_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41562-019-0545-2","volume":"3","author":"D Bavelier","year":"2019","unstructured":"Bavelier, D. et al. Rethinking human enhancement as collective welfarism. Nat. Hum. Behav. 3, 204\u2013206 (2019).","journal-title":"Nat. Hum. Behav."},{"key":"8300_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41586-019-00726-5","volume":"567","author":"ES Lander","year":"2019","unstructured":"Lander, E. S. et al. Adopt a moratorium on heritable genome editing. Nature 567, 165\u2013168 (2019).","journal-title":"Nature"},{"key":"8300_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMp1900504","volume":"380","author":"GQ Daley","year":"2019","unstructured":"Daley, G. Q., Lovell-Badge, R. & Steffann, J. After the storm\u2014a responsible path for genome editing. N. Engl. J. Med. 380, 897\u2013899 (2019).","journal-title":"N. Engl. J. Med."},{"key":"8300_CR7","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. Human Genome Editing: Science, Ethics, and Governance https:\/\/doi.org\/10.17226\/24623 (National Academies Press, Washington DC, 2017).","DOI":"10.17226\/24623"},{"key":"8300_CR8","doi-asserted-by":"publisher","unstructured":"National Academy of Medicine, National Academy of Sciences, and the Royal Society. Heritable Human Genome Editing https:\/\/doi.org\/10.17226\/256 (National Academies Press, Washington DC, 2020).","DOI":"10.17226\/256"},{"key":"8300_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr2105065","volume":"385","author":"P Turley","year":"2021","unstructured":"Turley, P. et al. Problems with using polygenic scores to select embryos. N. Engl. J. Med. 385, 78\u201386 (2021).","journal-title":"N. Engl. J. Med."},{"key":"8300_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher, P. M. et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5\u201322 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"8300_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"8300_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-022-05275-y","volume":"610","author":"L Yengo","year":"2022","unstructured":"Yengo, L. et al. A saturated map of common genetic variants associated with human height. Nature 610, 704\u2013712 (2022).","journal-title":"Nature"},{"key":"8300_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cell.2019.10.033","volume":"179","author":"E Karavani","year":"2019","unstructured":"Karavani, E. et al. Screening human embryos for polygenic traits has limited utility. Cell 179, 1424\u20131435.e8 (2019).","journal-title":"Cell"},{"key":"8300_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03351338","volume":"30","author":"H Bourne","year":"2012","unstructured":"Bourne, H., Douglas, T. & Savulescu, J. In vitro gametogenesis for genetic selection. Monash Bioethics Rev. 30, 29\u201348 (2012).","journal-title":"Monash Bioethics Rev."},{"key":"8300_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1216-0","volume":"18","author":"Y Wu","year":"2017","unstructured":"Wu, Y., Zheng, Z., Visscher, P. M. & Yang, J. Quantifying the mapping precision of genome-wide association studies using whole-genome sequencing data. Genome Biol, 18, 86 (2017).","journal-title":"Genome Biol,"},{"key":"8300_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41588-020-00735-5","volume":"52","author":"O Weissbrod","year":"2020","unstructured":"Weissbrod, O. et al. Functionally informed fine-mapping and polygenic localization of complex trait heritability. Nat. Genet. 52, 1355\u20131363 (2020).","journal-title":"Nat. Genet."},{"key":"8300_CR17","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1093\/nar\/gkaa239","volume":"48","author":"CJ Smith","year":"2020","unstructured":"Smith, C. J. et al. Enabling large-scale genome editing at repetitive elements by reducing DNA nicking. Nucleic Acids Res. 48, 5183\u20135195 (2020).","journal-title":"Nucleic Acids Res."},{"key":"8300_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41556-022-00975-z","volume":"24","author":"RS Zou","year":"2022","unstructured":"Zou, R. S. et al. Massively parallel genomic perturbations with multi-target CRISPR interrogates Cas9 activity and DNA repair at endogenous sites. Nat. Cell Biol. 24, 1433\u20131444 (2022).","journal-title":"Nat. Cell Biol."},{"key":"8300_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood.2022015825","volume":"140","author":"C Diorio","year":"2022","unstructured":"Diorio, C. et al. Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL. Blood 140, 619\u2013629 (2022).","journal-title":"Blood"},{"key":"8300_CR20","doi-asserted-by":"publisher","unstructured":"Oliynyk, R. T. Quantifying the potential for future gene therapy to lower lifetime risk of polygenic late-onset diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20133352 (2019).","DOI":"10.3390\/ijms20133352"},{"key":"8300_CR21","doi-asserted-by":"publisher","unstructured":"Oliynyk, R. T. Future preventive gene therapy of polygenic diseases from a population genetics perspective. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20205013 (2019).","DOI":"10.3390\/ijms20205013"},{"key":"8300_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1021\/acschembio.7b00842","volume":"13","author":"DB Thompson","year":"2018","unstructured":"Thompson, D. B. et al. The future of multiplexed eukaryotic genome engineering. ACS Chem. Biol. 13, 313\u2013325 (2018).","journal-title":"ACS Chem. Biol."},{"key":"8300_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"8300_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/d41586-023-03797-7","volume":"624","author":"H Ledford","year":"2023","unstructured":"Ledford, H. CRISPR 2.0: a new wave of gene editors heads for clinical trials. Nature 624, 234\u2013235 (2023).","journal-title":"Nature"},{"key":"8300_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrg3502","volume":"14","author":"M Parkes","year":"2013","unstructured":"Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661\u2013673 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"8300_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41588-018-0101-4","volume":"50","author":"J Zeng","year":"2018","unstructured":"Zeng, J. et al. Signatures of negative selection in the genetic architecture of human complex traits. Nat. Genet. 50, 746\u2013753 (2018).","journal-title":"Nat. Genet."},{"key":"8300_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08424-6","volume":"10","author":"AP Schoech","year":"2019","unstructured":"Schoech, A. P. et al. Quantification of frequency-dependent genetic architectures in 25 UK Biobank traits reveals action of negative selection. Nat. Commun. 10, 790 (2019).","journal-title":"Nat. Commun."},{"key":"8300_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia. N. Engl. J. Med. 384, 252\u2013260 (2021).","journal-title":"N. Engl. J. Med."},{"key":"8300_CR29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.0711566105","volume":"105","author":"M Uda","year":"2008","unstructured":"Uda, M. et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl Acad. Sci. USA 105, 1620\u20131625 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8300_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"8300_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/d41573-021-00093-9","volume":"20","author":"K Kingwell","year":"2021","unstructured":"Kingwell, K. Pushing the envelope with PCSK9. Nat. Rev. Drug. Discov. 20, 506 (2021).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"8300_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"JB Rosenberg","year":"2018","unstructured":"Rosenberg, J. B. et al. AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer\u2019s disease. Hum. Gene Ther. Clin. Dev. 29, 24\u201347 (2018).","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"8300_CR33","volume-title":"In the Name of Eugenics","author":"DJ Kevles,","year":"1998","unstructured":"Kevles, D. J. In the Name of Eugenics (Harvard Univ. Press, 1998)."},{"key":"8300_CR34","volume-title":"The Imperative of Responsibility: In Search of an Ethics for the Technological Age,","author":"H Jonas,","year":"1984","unstructured":"Jonas,H. The Imperative of Responsibility: In Search of an Ethics for the Technological Age, Vol. 11 (Univ. of Chicago Press, 1984)."},{"key":"8300_CR35","volume-title":"Anarchy, State, and Utopia","author":"R Nozick,","year":"1974","unstructured":"Nozick,R. Anarchy, State, and Utopia, Vol. 7 (Basic Books, 1974)."},{"key":"8300_CR36","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511806940","volume-title":"From Chance to Choice: Genetics and Justice","author":",A, Buchanan","year":"2000","unstructured":"Buchanan, A., Brock, D. W., Daniels,N. & Wikler,D. From Chance to Choice: Genetics and Justice (Cambridge Univ. Press, 2000)."},{"key":"8300_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0968533214520845","volume":"13","author":"DR Lawrence","year":"2013","unstructured":"Lawrence, D. R. To what extent is the use of human enhancements defended in international human rights legislation? Med. Law Int. 13, 254\u2013278 (2013).","journal-title":"Med. Law Int."},{"key":"8300_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40592-014-0014-7","volume":"32","author":"M Dunlop","year":"2014","unstructured":"Dunlop, M. & Savulescu, J. Distributive justice and cognitive enhancement in lower, normal intelligence. Monash Bioethics Rev. 32, 189\u2013204 (2014).","journal-title":"Monash Bioethics Rev."},{"key":"8300_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/1467-8519.00251","volume":"15","author":"J Savulescu","year":"2004","unstructured":"Savulescu, J. Procreative beneficence: why we should select the best children. Bioethics 15, 413\u2013426 (2004).","journal-title":"Bioethics"},{"key":"8300_CR40","doi-asserted-by":"crossref","unstructured":"Giubilini, A. & Sanyal, S. in The Ethics of Human Enhancement (eds Clarke, S., Savulescu, J., Coady, T., Giubilini, A. & Sanyal, S.) 1\u201324 (Oxford Univ. Press, 2016).","DOI":"10.1093\/acprof:oso\/9780198754855.003.0001"},{"key":"8300_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13347-012-0086-3","volume":"25","author":"C Gyngell","year":"2012","unstructured":"Gyngell, C. Enhancing the species: genetic engineering technologies and human persistence. Philos. Technol. 25, 495\u2013512 (2012).","journal-title":"Philos. Technol."},{"key":"8300_CR42","unstructured":"Kass, L. R. Ageless bodies, happy souls: biotechnology and the pursuit of perfection. New Atlantis Spring 2003, 9\u201328 (2003)."},{"key":"8300_CR43","doi-asserted-by":"crossref","unstructured":"Bostrom, N. & Sandberg, A. in Philosophical Issues in Pharmaceutics vol. 122 (ed. Ho, D.) 189\u2013219 (Springer Netherlands, Dordrecht, 2017).","DOI":"10.1007\/978-94-024-0979-6_12"},{"key":"8300_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15265161.2021.1907480","volume":"22","author":"R Sparrow","year":"2022","unstructured":"Sparrow, R. Human germline genome editing: on the nature of our reasons to genome edit. Am. J. Bioeth. 22, 4\u201315 (2022).","journal-title":"Am. J. Bioeth."},{"key":"8300_CR45","unstructured":"WHO Guidelines for the Prevention of Sexual Transmission of Zika Virus (World Health Organization)."},{"key":"8300_CR46","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2307\/3527746","volume":"29","author":"E Parens","year":"1999","unstructured":"Parens, E. & Asch, A. Special supplement: The disability rights critique of prenatal genetic testing reflections and recommendations. Hastings Center Report 29, S1\u2013S22 (1999).","journal-title":"Hastings Center Report"},{"key":"8300_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jme.25.2.163","volume":"25","author":"L Gillam","year":"1999","unstructured":"Gillam, L. Prenatal diagnosis and discrimination against the disabled. J. Med. Ethics 25, 163\u2013171 (1999).","journal-title":"J. Med. Ethics"},{"key":"8300_CR48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/ejhg.2010.90","volume":"18","author":"NE Cousens","year":"2010","unstructured":"Cousens, N. E., Gaff, C. L., Metcalfe, S. A. & Delatycki, M. B. Carrier screening for beta-thalassaemia: a review of international practice. Eur. J. Hum. Genet. 18, 1077\u20131083 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"8300_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bioe.12570","volume":"33","author":"J Savulescu","year":"2019","unstructured":"Savulescu, J. & Singer, P. An ethical pathway for gene editing. Bioethics 33, 221\u2013222 (2019).","journal-title":"Bioethics"},{"key":"8300_CR50","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/9780262026635.003.0007","volume-title":"Truly Human Enhancement: A Philosophical Defense of Limits","author":",N Agar","year":"2014","unstructured":"Agar, N. Truly Human Enhancement: A Philosophical Defense of Limits (Oxford Univ. Press, 2014)."},{"key":"8300_CR51","volume-title":"Better Than Well: American Medicine Meets the American Dream","author":",C Elliott","year":"2010","unstructured":"Elliott, C. Better Than Well: American Medicine Meets the American Dream (Norton Agency Titles, 2010)."},{"key":"8300_CR52","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/medethics-2019-105436","volume":"45","author":"E Kleiderman","year":"2019","unstructured":"Kleiderman, E., Ravitsky, V. & Knoppers, B. M. The \u2018serious\u2019 factor in germline modification. J. Med. Ethics 45, 508\u2013513 (2019).","journal-title":"J. Med. Ethics"},{"key":"8300_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106588","author":"S Munday","year":"2021","unstructured":"Munday, S. & Savulescu, J. Three models for the regulation of polygenic scores in reproduction. J. Med. Ethics https:\/\/doi.org\/10.1136\/medethics-2020-106588 (2021).","journal-title":"J. Med. Ethics"},{"key":"8300_CR54","unstructured":"Funk,C. et l. Biotechnology research viewed with caution globally, but most support gene editing for babies to treat disease. Pew Research Center https:\/\/www.pewresearch.org\/science\/2020\/12\/10\/biotechnology-research-viewed-with-caution-globally-but-most-support-gene-editing-for-babies-to-treat-disease\/ (2020)."},{"key":"8300_CR55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1126\/science.ade1083","volume":"379","author":"MN Meyer","year":"2023","unstructured":"Meyer, M. N., Tan, T., Benjamin, D. J., Laibson, D. & Turley, P. Public views on polygenic screening of embryos. Science 379, 541\u2013543 (2023).","journal-title":"Science"},{"key":"8300_CR56","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41588-022-01242-5","volume":"54","author":"D Greenbaum","year":"2022","unstructured":"Greenbaum, D. & Gerstein, M. GATTACA is still pertinent 25 years later. Nat. Genet. 54, 1758\u20131760 (2022).","journal-title":"Nat. Genet."},{"key":"8300_CR57","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.2105\/AJPH.2009.166082","volume":"100","author":"PA Braveman","year":"2010","unstructured":"Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R. & Pamuk, E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am. J. Public Health 100, S186\u2013S196 (2010).","journal-title":"Am. J. Public Health"},{"key":"8300_CR58","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41562-019-0757-5","volume":"3","author":"A Abdellaoui","year":"2019","unstructured":"Abdellaoui, A. et al. Genetic correlates of social stratification in Great Britain. Nat. Hum. Behav. 3, 1332\u20131342 (2019).","journal-title":"Nat. Hum. Behav."},{"key":"8300_CR59","unstructured":"Robinson, M. R. et al. Genetic evidence of assortative mating in humans. Nat. Hum. Behav. 1, 0016 (2017)."},{"key":"8300_CR60","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctv1htpf72","volume-title":"The Genetic Lottery: Why DNA Matters for Social Equality","author":"KP Harden,","year":"2021","unstructured":"Harden,K. P. The Genetic Lottery: Why DNA Matters for Social Equality (Princeton Univ. Press, 2021)."},{"key":"8300_CR61","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584\u2013591 (2019).","journal-title":"Nat. Genet."},{"key":"8300_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jmp\/jhq004","volume":"37","author":"R Powell","year":"2012","unstructured":"Powell, R. The evolutionary biological implications of human genetic engineering. J. Med. Philos. 37, 204\u2013225 (2012).","journal-title":"J. Med. Philos."},{"key":"8300_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1467-8519.2004.00376.x","volume":"18","author":"F Baylis","year":"2004","unstructured":"Baylis, F. & Robert, J. S. The inevitability of genetic enhancement technologies. Bioethics 18, 1\u201326 (2004).","journal-title":"Bioethics"},{"key":"8300_CR64","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1534\/genetics.115.180471","volume":"202","author":"M Lynch","year":"2016","unstructured":"Lynch, M. Mutation and human exceptionalism: our future genetic load. Genetics 202, 869\u2013875 (2016).","journal-title":"Genetics"},{"key":"8300_CR65","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1534\/genetics.116.192096","volume":"204","author":"FP Roth","year":"2016","unstructured":"Roth, F. P. & Wakeley, J. Taking exception to human eugenics. Genetics 204, 821\u2013823 (2016).","journal-title":"Genetics"},{"key":"8300_CR66","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1534\/genetics.118.301093","volume":"210","author":"A Teicher","year":"2018","unstructured":"Teicher, A. Caution, overload: the troubled past of genetic load. Genetics 210, 747\u2013755 (2018).","journal-title":"Genetics"},{"key":"8300_CR67","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1534\/genetics.116.194621","volume":"204","author":"M Lynch","year":"2016","unstructured":"Lynch, M. Mutation, eugenics, and the boundaries of science. Genetics 204, 825\u2013827 (2016).","journal-title":"Genetics"},{"key":"8300_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni, R. E. et al. GWAS on family history of Alzheimer\u2019s disease. Transl. Psychiatry 8, 99 (2018).","journal-title":"Transl. Psychiatry"},{"key":"8300_CR69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343\u2013352 (2019).","journal-title":"Nat. Neurosci."},{"key":"8300_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"8300_CR71","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","volume":"52","author":"M Vujkovic","year":"2020","unstructured":"Vujkovic, M. et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat. Genet. 52, 680\u2013691 (2020).","journal-title":"Nat. Genet."},{"key":"8300_CR72","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","volume":"54","author":"KG Aragam","year":"2022","unstructured":"Aragam, K. G. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803\u20131815 (2022).","journal-title":"Nat. Genet."},{"key":"8300_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19366-9","volume":"12","author":"V Lagou","year":"2021","unstructured":"Lagou, V. et al. Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat. Commun. 12, 24 (2021).","journal-title":"Nat. Commun."},{"key":"8300_CR74","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600, 675\u2013679 (2021).","journal-title":"Nature"},{"key":"8300_CR75","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-024-01714-w","volume":"56","author":"JM Keaton","year":"2024","unstructured":"Keaton, J. M. et al. Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. Nat. Genet. 56, 778\u2013791 (2024).","journal-title":"Nat. Genet."},{"key":"8300_CR76","doi-asserted-by":"publisher","unstructured":"Visscher, P., Gyngell, C., Yengo, L. & Savulescu, J. Heritable polygenic gene editing: the next frontier in genomic medicine? Zenodo https:\/\/doi.org\/10.5281\/zenodo.7513325 (2024).","DOI":"10.5281\/zenodo.7513325"}],"updated-by":[{"DOI":"10.1038\/s41586-025-08904-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08300-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T03:26:22Z","timestamp":1742873182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":76,"journal-issue":{"issue":"8046","published-print":{"date-parts":[[2025,1,16]]}},"alternative-id":["8300"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08300-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41586-025-08904-4","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-08904-4","URL":"https:\/\/doi.org\/10.1038\/s41586-025-08904-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S. is a Partner Investigator on an Australian Research Council grant LP190100841, which involves an industry partnership from Illumina. He does not personally receive any funds from Illumina. He is a Bioethics Committee consultant for Bayer and a Bioethics Advisor to the Hevolution Foundation. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}